Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Dr. Reddy's Laboratories Ltd ADR (RDY)
Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,078,992
  • Shares Outstanding, K 166,587
  • Annual Sales, $ 3,073 M
  • Annual Income, $ 563,340 K
  • 60-Month Beta 0.49
  • Price/Sales 3.03
  • Price/Cash Flow 12.85
  • Price/Book 3.14
Trade RDY with:

Options Overview Details

View History
  • Implied Volatility 19.96% ( +2.74%)
  • Historical Volatility 25.28%
  • IV Percentile 27%
  • IV Rank 42.85%
  • IV High 46.40% on 10/18/22
  • IV Low 0.13% on 04/12/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 14
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 235
  • Open Int (30-Day) 283

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.71
  • Number of Estimates 1
  • High Estimate 0.71
  • Low Estimate 0.71
  • Prior Year 0.90
  • Growth Rate Est. (year over year) -21.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.12 +2.60%
on 05/18/23
61.40 -11.24%
on 05/02/23
-4.97 (-8.36%)
since 04/26/23
3-Month
52.24 +4.33%
on 02/28/23
61.40 -11.24%
on 05/02/23
+0.33 (+0.61%)
since 02/24/23
52-Week
49.79 +9.45%
on 09/26/22
61.40 -11.24%
on 05/02/23
-0.77 (-1.39%)
since 05/26/22

Most Recent Stories

More News
Dr. Reddy's Laboratories (RDY) Is the Pharmaceutical Stock to Buy

Dr. Reddy's Laboratories (RDY) delivered exceptional performance, as its fourth-quarter profits grew by an astonishing eleven-fold. By deftly expanding its product line-up and fortifying its market presence,...

ABBV : 137.56 (-0.76%)
BMY : 63.82 (-1.15%)
NVS : 97.86 (+0.08%)
RDY : 54.50 (+0.07%)
Dr. Reddy's (RDY) Q4 Earnings and Revenues Beat Estimates

Dr. Reddy's (RDY) reports better-than-expected fourth-quarter results where both earnings and revenues beat estimates.

RDY : 54.50 (+0.07%)
IMGN : 14.00 (+1.30%)
AZYO : 2.04 (-0.97%)
BTTX : 0.7115 (+3.12%)
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

RDY : 54.50 (+0.07%)
Dr. Reddy's Laboratories Announces the Launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the launch of Regadenoson Injection...

RDY : 54.50 (+0.07%)
Growth: These 3 Stocks Continue to Grow as April 2023 Nears an End

While inflation has been declining, rising fears of a recession as a result of the recent financial crisis are expected to put the stock market under pressure. Fundamentally strong stocks, such as Fast...

FRCOY : 23.9600 (+0.45%)
PBPB : 7.69 (-1.28%)
RDY : 54.50 (+0.07%)
Zacks.com featured highlights Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger

Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger have been highlighted in this Screen of The Week article.

RDY : 54.50 (+0.07%)
DRI : 161.28 (+0.16%)
MCHP : 78.32 (+5.64%)
GWW : 664.23 (+0.70%)
NSP : 110.45 (-0.02%)
Dr. Reddy's Laboratories Announces the Launch of Treprostinil Injection in the U.S.

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the launch of Treprostinil Injection...

RDY : 54.50 (+0.07%)
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan

Aditxt,® Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to announce...

RDY : 54.50 (+0.07%)
ADTX : 0.5980 (-1.29%)
Strength Seen in Amphastar (AMPH): Can Its 6.4% Jump Turn into More Strength?

Amphastar (AMPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

AMPH : 44.14 (+0.20%)
RDY : 54.50 (+0.07%)
U.S. Economy Suffering From Dichotomy: 5 Safe Stocks

We have selected five defensive stocks with strong momentum. These are: CAG, COTY, NEE, NJR, RDY.

NEE : 73.92 (+0.72%)
RDY : 54.50 (+0.07%)
CAG : 34.84 (+0.32%)
NJR : 48.96 (+0.18%)
COTY : 11.03 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through...

See More

Key Turning Points

3rd Resistance Point 55.47
2nd Resistance Point 55.22
1st Resistance Point 54.86
Last Price 54.50
1st Support Level 54.25
2nd Support Level 54.00
3rd Support Level 53.64

See More

52-Week High 61.40
Fibonacci 61.8% 56.97
Fibonacci 50% 55.60
Last Price 54.50
Fibonacci 38.2% 54.23
52-Week Low 49.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar